Table 2.
Crude event rates by quintile of visit-to-visit variability of systolic blood pressure defined as the coefficient of variation or average real variability among 114,900 adults with chronic kidney disease stage 3–4.
Visit-to-Visit Variability in Blood Pressure Using Coefficient of Variation | |||||
---|---|---|---|---|---|
| |||||
1st Quintile | 2nd Quintile | 3rd Quintile | 4th Quintile | 5th Quintile | |
Death | |||||
Events, N | 721 | 878 | 992 | 1194 | 1329 |
Rate per 100 p-y (95% CI) | 3.23 (2.99, 3.47) | 3.95 (3.69, 4.21) | 4.48 (4.20, 4.76) | 5.42 (5.11, 5.73) | 6.05 (5.73, 6.38) |
End-stage renal disease | |||||
Events, N | 50 | 90 | 133 | 162 | 147 |
Rate per 100 p-y (95% CI) | 0.22 (0.16, 0.29) | 0.41 (0.32, 0.49) | 0.60 (0.50, 0.70) | 0.74 (0.62, 0.85) | 0.67 (0.56, 0.78) |
Acute coronary syndrome | |||||
Events, N | 194 | 214 | 249 | 292 | 340 |
Rate per 100 p-y (95% CI) | 0.87 (0.75, 0.99) | 0.96 (0.83, 1.09) | 1.12 (0.98, 1.26) | 1.33 (1.17, 1.48) | 1.55 (1.38, 1.71) |
Heart failure | |||||
Events, N | 270 | 423 | 520 | 660 | 655 |
Rate per 100 p-y (95% CI) | 1.21 (1.07, 1.35) | 1.90 (1.72, 2.09) | 2.35 (2.15, 2.55) | 3.00 (2.77, 3.22) | 2.98 (2.76, 3.21) |
Ischemic Stroke | |||||
Events, N | 138 | 133 | 144 | 193 | 209 |
Rate per 100 p-y (95% CI) | 0.62 (0.52, 0.72) | 0.60 (0.50, 0.70) | 0.65 (0.54, 0.76) | 0.88 (0.75, 1.00) | 0.95 (0.82, 1.08) |
Hemorrhagic Stroke | |||||
Events, N | 96 | 146 | 187 | 185 | 213 |
Rate per 100 p-y (95% CI) | 0.43 (0.34, 0.52) | 0.66 (0.55, 0.76) | 0.84 (0.72, 0.97) | 0.84 (0.72, 0.96) | 0.97 (0.84, 1.10) |
Visit-to-Visit Variability in Blood Pressure Using Average Real Variability | |||||
---|---|---|---|---|---|
| |||||
1st Quintile | 2nd Quintile | 3rd Quintile | 4th Quintile | 5th Quintile | |
Death | |||||
Events, N | 761 | 1009 | 1070 | 1108 | 1166 |
Rate per 100 p-y (95% CI) | 3.45 (3.21–3.70) | 4.54 (4.26–4.82) | 5.08 (4.77–5.38) | 4.98 (4.69–5.28) | 5.05 (4.76–5.34) |
End-stage renal disease | |||||
Events, N | 42 | 99 | 129 | 154 | 158 |
Rate per 100 p-y (95% CI) | 0.19 (0.13–0.25) | 0.45 (0.36–0.53) | 0.61 (0.51–0.72) | 0.69 (0.58–0.80) | 0.69 (0.58–0.79) |
Acute coronary syndrome | |||||
Events, N | 191 | 227 | 239 | 295 | 337 |
Rate per 100 p-y (95% CI) | 0.87 (0.74–0.99) | 1.02 (0.89–1.15) | 1.13 (0.99–1.28) | 1.33 (1.18–1.48) | 1.46 (1.30–1.62) |
Heart failure | |||||
Events, N | 307 | 485 | 534 | 602 | 600 |
Rate per 100 p-y (95% CI) | 1.39 (1.24–1.55) | 2.18 (1.99–2.38) | 2.53 (2.32–2.75) | 2.71 (2.49–2.92) | 2.60 (2.39–2.81) |
Ischemic Stroke | |||||
Events, N | 133 | 143 | 142 | 173 | 226 |
Rate per 100 p-y (95% CI) | 0.60 (0.50–0.71) | 0.64 (0.54–0.75) | 0.67 (0.56–0.78) | 0.78 (0.66–0.89) | 0.98 (0.85–1.11) |
Hemorrhagic Stroke | |||||
Events, N | 130 | 105 | 213 | 174 | 205 |
Rate per 100 p-y (95% CI) | 0.59 (0.49–0.69) | 0.47 (0.38–0.56) | 1.01 (0.87–1.15) | 0.78 (0.67–0.90) | 0.89 (0.77–1.01) |